Embattled genetic testing provider 23andMe said Tuesday that revenue declined from a year earlier, a day after the company announced a cost-cutting plan.
Related Posts
Americans are getting flashbacks to 2008 as tariffs stoke recession fears
‘It’s the old poors teaching the new poors,’ said one content creator.
Stock futures are little changed after S&P 500 notches three-day win streak: Live updates
The major averages posted marginal gains on Tuesday, with the broad market index registering a three-day winning run.
Apple leads a drop in tech stocks after Trump tariff announcement
Tech stocks fell in late trading Wednesday following President Donald Trump’s announcement of reciprocal tariffs.